The Journal of Phytopharmacology, 2020;9(1):38-45 ; DOI:10.31254/phyto.2020.9107
Identification of PTPN1B inhibitors from Momordica charantia and their enrichment analysis
Prarambh SR Dwivedi1 , VP Rasal1
1. Department of Pharmacology, KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research (KAHER), Belagavi-590010, India
*Author to whom correspondence should be addressed.
Received: 27th January, 2020 / Accepted: 1st March, 2020
Background: PTPN1B is identified to play a prime role in a negative role in the insulin signaling pathway which can be inhibited and could contribute to the enhancement of insulin function. Objective: The present study aimed to identify PTPN 1B inhibitors from Momordica charantia and perform gene set enrichment analysis of regulated protein molecules. Methods: The phytoconstituents present in Momordica charantia were identified and queried for PTPN1B inhibitors. Druglikeness score, side effects and gene expression were predicted for each compound. A docking study was performed to predict the binding affinity with PTPN1B receptor; later the binding affinities were compared. Kyoto Encyclopedia of Genes and Genomes pathway analysis was performed for the regulated genes to identify the modulated pathways. Results: Among the forty-four identified compounds present in Momordica charantia thirtythree compounds were found to inhibit PTPN 1B. Momordin I possessed the highest binding affinity with PTPN1B. Cytokine-cytokine receptor pathway was predicted to modulate the most amounts of protein molecules in diabetes mellitus. The side effects of these compounds were also estimated and only three compounds showed side effects when Pa?0.7. Conclusion: The present study indicates that PTPN 1B inhibitors from Momordica charantia have their anti-diabetic action due to their action on multiple protein molecules and the synergistic effect can be confirmed by future investigations.
Diabetes, Docking, Momordica charantia, PTPN1B inhibitors
HOW TO CITE THIS ARTICLE
Dwivedi PSR, Rasal VP. Identification of PTPN1B inhibitors from Momordica charantia and their enrichment analysis. J Phytopharmacol 2020; 9(1):38-45.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.